Skip to content
Other

Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation

Zoetis Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation decreased by 178.4% to -$509M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 53.3%, from -$332M to -$509M.

Analysis

StatementIncome Statement
SectionOther
First reportedQ3 2020
Last reportedQ1 2026May 7, 2026
Metric ID: other_cash_cash_equivalents_restricted_cash_and_restrict_8b4577

Historical Data

13 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q1 '24Q2 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$56M-$384M-$350M-$483M-$145M-$1.47B-$392M-$66M-$401M-$332M-$220M$649M-$509M
QoQ Change-785.7%+8.9%-38.0%+70.0%-915.2%+73.4%+83.2%-507.6%+17.2%+33.7%+395.0%-178.4%
YoY Change-962.5%+62.2%-320.6%+18.8%+95.5%-2.3%-403.0%+45.1%-53.3%
Range-$1.47B$649M
CAGR+108.7%
Avg YoY Growth-168.9%
Median YoY Growth-2.3%

Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation at Other Companies

Frequently Asked Questions

What is Zoetis's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation?
Zoetis (ZTS) reported cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation of -$509M in Q1 2026.
How has Zoetis's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation changed year-over-year?
Zoetis's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation decreased by 53.3% year-over-year, from -$332M to -$509M.